PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
10.19%
Revenue growth exceeding 1.5x CRWD's 5.94%. David Dodd would verify if faster growth reflects superior business model.
-2.17%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
11.91%
Gross profit growth exceeding 1.5x CRWD's 5.45%. David Dodd would verify competitive advantages.
1.56%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.20%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
7.00%
Total costs growth above 1.5x CRWD's 4.38%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
55.32%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
19.70%
EBITDA growth while CRWD declines. John Neff would investigate advantages.
34.58%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
15.66%
Operating income growth exceeding 1.5x CRWD's 9.37%. David Dodd would verify competitive advantages.
4.97%
Operating margin growth below 50% of CRWD's 14.45%. Michael Burry would check for structural issues.
-526.09%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-12.79%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-20.85%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-15.44%
Both companies reducing tax expense. Martin Whitman would check patterns.
-11.42%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-19.61%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.42%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-11.42%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.